Discovering Mast Cells' Role in Eosinophilic Oesophagitis with Machine Learning

Explore how a recent study used machine learning to localise and characterise mast cells in the pathology of EoE. Read more

EOS Network Advocacy: Key Highlights from ESPGHAN 2024 Annual Meeting

Learn more about our paediatric care advocacy, networking and learn about the latest research we bring from the ESPGHAN Annual Meeting Read more

EOS Network's Advocacy at the London Marathon 2024

Learn more about EOS Network's participation at the London Marathon 2024, raising awareness for people with Eosinophil-Associated diseases. Read more

Persistent Asthma Symptoms in Children on Mepolizumab

Explore a study that aims to understand why some people on eosinophil-directed treatments continue to have Eosinophilic Asthma flare-ups. Read more

Fasenra Outperforms Nucala in EGPA Steroid Reduction: MANDARA Study Findings

Discover how Fasenra outperforms Nucala in treating Granulomatosis with Polyangiitis (EGPA), offering hope for reduced steroid use and improved remission. Read more

Total Wall Thickness: A New Diagnostic Tool for Paediatric Eosinophilic Oesophagitis

Discover how Total Wall Thickness measurement is transforming the diagnosis and management of Paediatric Eosinophilic Oesophagitis (EoE), offering a more direct insight into treatment efficacy and disease progression. Read more

FDA Approves EOHILIA For Treating EoE in The US

FDA approves Takeda's EOHILIA® for treating Eosinophilic Oesophagitis (EoE). Learn more about the medication's mechanism of action. Read more

FDA Approves Dupixent As EoE Treatment For Children From One to Eleven

FDA has approved Dupixent (dupilumab) for children aged one to eleven, an important step for EoE management in young children and families. Read more

EOS Network facilitates Cyted's Innovative Study on EoE Capsule Sponge Test

Discover how the EOS Network collaborates with Cyted to explore the capsule sponge test using EndoSign®, a promising alternative to endoscopic biopsies for EoE management. This study aims to improve patient experience and advance EoE treatment monitoring. Read more

Maternal and Infant Antibiotic and Acid Suppressant Use and Risk of Eosinophilic Oesophagitis

New research reveals that the use of antibiotics and acid suppressants by mothers and infants may increase the risk of developing Eosinophilic Oesophagitis. Read more

Pollen Season and EoE: How It Affects Diet Treatment

Pollen season can lower the response rate to the six-food elimination diet (SFED) in patients with Eosinophilic Oesophagitis (EoE), study shows. Read more

A New Study Shows the Potential of Blood Biomarkers for Eosinophilic Oesophagitis

This study sheds light on non-invasive blood biomarkers to potentially diagnose and manage Eosinophilic Oesophagitis. Read more

Eosinophilic Oesophagitis and Asthma: A Revealing Connection in Hospital Visits

A study shows that patients with eosinophilic oesophagitis (EoE) and asthma seek hospital care earlier than those with only one condition. Read more

EOS Network at 75th BSACI Conference: Networking and Advancements in Eosinophilic Diseases

EOS Network attended the 75th BSACI Conference to connect with healthcare professionals and advocate for EoE awareness. Read more

FDA Grants Priority Review for Dupixent (dupilumab) in Treating Eosinophilic Oesophagitis in Children

Learn more about Dupixent and what impact its approval could have on treating EoE in younger children. Read more

Health Disparities in Children with Eosinophilic Oesophagitis

Learn more about differences existing in care for children with eosinophilic oesophagitis, depending on race, urbanisation, and socioeconomic status. Read more

Takeda's Resubmission of EoE Drug For FDA Approval

FDA to review Takeda's resubmission of Budesonide oral suspension - NDA of TAK-721, offering new hope for Eosinophilic Oesophagitis (EoE) patients. What does this mean for the eosinophilic community? Read more

Study: Weekly Doses of Dupilumab Are The Most Effective at Managing Eosinophilic Oesophagitis

Recent research shows weekly dupilumab outperforms bi-weekly treatments in managing Eosinophilic Oesophagitis (EoE) symptoms. Read more

TSLP: A Pathway to Non-Invasive Blood Tests and Targeted Treatments

Learn how groundbreaking research on Thymic Stromal Lymphopoietin (TSLP) offers hope for more effective and less invasive diagnoses and treatments for eosinophilic diseases like EoE. Read more

Overcoming The Inequalities in Eosinophilic Gastrointestinal Disease Research

Learn how CEGIR promotes diversity, equity, inclusion, and accessibility in research and treatments for people with Eosinophilic-associated Diseases. Read more

Achalasia's Association with Eosinophilic Oesophagitis and Other Allergic Diseases

Recent findings highlight an association between achalasia and Eosinophilic Oesophagitis (EoE) in 6.5% of achalasia patients. Understanding this rare link may improve treatment options for both conditions, potentially benefiting those with EoE and achalasia. Read more

Defining EoE Phenotypes Using Functional Lumen Imaging Probe (FLIP)

Explore new research findings on how FLIP panometry can be used to classify Eosinophilic Esophagitis (EoE) patients by disease severity. This innovative method could pave the way for personalised treatment plans, improving patient outcomes. Read more